The linearized multistage model and the future of quantitative risk assessment

Human & Experimental Toxicology

Volumn 15, Issue 10, 1996, Pages 787-798

  Crump, Kenny S ^a  

^a ICF Kaiser International   (United States)

Author keywords

biologically based model; cancer; linearized multi stage model; risk assessment; U.S. EPA;

Indexed keywords

CARCINOGEN;

ARTICLE; BIOLOGICAL MODEL; CANCER RISK; DOSE RESPONSE; GOVERNMENT; HUMAN; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL MODEL; UNITED STATES;

ANIMALS; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; MODELS, THEORETICAL; NEOPLASMS, EXPERIMENTAL; PHARMACOKINETICS; RISK ASSESSMENT; SOFTWARE; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

ANIMALIA; UNIDENTIFIED AGENTS;

EID: 0029806189     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719601501001     Document Type: Article

References (50)

1. Guess H., Crump K. Low-dose extrapolation of data from animal carcinogenesis experiments - analysis of a new statistical technique. Math Biosc 1976; 32: 15-36.
2. Anderson EL and the Carcinogen Assessment Group of the US Environmental Protection Agency. Quantitative approaches in use to assess cancer risk. Risk Analysis 1983; 3: 277 - 95.
3. US Environmental Protection Agency. Guidelines for carcinogenic risk assessment. Federal Register 1986; 51(185): 33992-4003.
4. US Environmental Protection Agency. Proposed Guidelines for Carcinogen Risk Assessment. Office of Research and Development. EPA/600/P-92/ 003C. Washington, DC (April, 1996).
5. Lovell DP, Thomas G. Quantitative risk assessment and the limitations of the linearized multistage model. Human & Experimental Toxicology 1996; 15: 87-104.
6. Albert RE Carcinogen risk assessment in the U.S. Environmental Protection Agency. Critical Reviews in Toxicology 1994; 24: 75 - 85
7. National Research Council. Drinking Water and Health. Safe Drinking Water Committee, Assembly of Life Sciences, National Academy of Sciences, Washington, DC. 1977.
8. Crump K., Hoel D., Langley C., Peto R. Fundamental carcinogenic processes and their implications to low dose risk assessment. Cancer Res 1976; 36: 2973-9.
9. Peto R. Carcinogenic effects of chronic exposure to very low levels of toxic substances. Environmental Health Perspectives 1978; 22: 155-9.
10. Crump K., Guess H., Deal K. Confidence intervals and tests of hypotheses inferred from animal carcinogenicity data. Biometrics 1977; 33: 437-51.
11. Guess H., Crump K. Maximum likelihood estimation of dose-response functions subject to absolutely monotonic constraints. Ann Stat 1978; 6: 101-11.
12. Crump K. An improved procedure for low-dose carcinogenic risk assessment from animal data. J Environ Pathol Toxicol 1984; 5: 339-48.
13. Crump KS, Crockett P. Improved confidence limits for low-dose carcinogenic risk assessment from animal data. J Hazardous Materials 1985; 10: 419-31.
14. Mantel N., Bryan WR Safety testing of carcinogenic agents. J Nat Cancer Inst 1961; 27: 455-70.
15. Hartley HO, Sielken RL Estimation of‘safe doses’ in carcinogenic experiments. Biometrics 1977; 33: 1-30.
16. Altshuler B. A bayesian approach to assessing population risks from environmental carcinogens. In: AS Whittemore (ed.), Environmental Health: Quantitative Methods. Philadelphia: Society for Industrial and Applied Mathematics, 1977.
17. Cornfield J., Carlborg FW, Van Ryzin J. Setting tolerance on the basis of mathematical treatment of dose. Proceedings of the First International Toxicology Conference, 1978.
18. US Environmental Protection Agency. Water quality criteria, request for comments. Federal Register 1979; 44 (55): 15926-81.
19. Armitage P., Doll R. Stochastic models for carcinogenesis. In: Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, Vol. 4, 19-38. Berkeley and Los Angeles: University of California Press, 1961.
20. Clewell HJ, Andersen ME Risk assessment extrapolations and physiological modelling. Toxicol Ind Health 1985; 1 (4): 111-31.
21. US Environmental Protection Agency. Request for comments on draft report of cross-species scaling factor for cancer risk assessment. Fed Reg 1992; 57: 24152.
22. Crump KS Mechanisms leading to dose-response models. In: Ricci P, ed. Principles of Health Risk Assessment. Prentice-Hall. pp. 235-277, 1985.
23. Moolgavkar SH The multistage theory of carcinogenesis and the age distribution of cancer in man. Journal of the National Cancer Institute 1978; 61: 49-52.
24. Guess H., Crump KS Can we use animal experiments to estimate‘safe’ doses for chemical carcinogens? In: Whittemore A, ed. Environmental Health: Quantitative Methods. SIAM: Philadelphia, PA. pp. 13-30, 1977.
25. Guess H., Crump KS, Peto R. Uncertainty estimates for low-dose extrapolations of animal carcinogenicity data. Cancer Res 1977; 37: 3475-83.
26. Crump KS Statistical aspects of linear extrapolation. In: Richmond CR, Walsh P, Copenhaver D, eds. Proceedings of the Third Life Sciences Symposium, Health Risk Analysis. Gatlinburg, TN. October, 1980. pp. 381-392, 1981.
27. Krewski D. et al. A comparison of statistical methods for low-dose extrapolation utilizing time-to-tumour data. Fund Appl Toxicol 1983; 3: 140-60.
28. Daffer P., Crump KS, Masterman M. Asymptotic theory for analyzing dose response survival data with application to the low-dose extrapolation problem. Math Biosci 1980; 50: 207-30.
29. Crump KS, Howe RB, Van Landingham C. TOX_RISK: Toxicology Risk Assessment Program. Clement Associates, KS Crump Division, Ruston, LA., 1990.
30. Howe RB, Crump KS, Van Landingham C. Global 86: A Computer Program to Extrapolate Quantal Animal Toxicity Data to Low Doses. Prepared for Environmental Protection Agency under Subcontract 2-251U-2745 to Research Triangle Institute, 1986.
31. Leung HW Development and utilization of physiologically based pharmacokinetic models for toxicological applications. J Toxicol Environ Health 1991; 32: 247-67.
32. Clewell HJ, Andersen ME Biologically motivated models for chemical risk assessment. Health Physics 1989; 57 (Suppl. 1): 129-37.
33. National Research Council. Pharmacokinetics in Risk Assessment. Drinking Water and Health. Volume 8. National Academy Press, Washington D.C., 1987.
34. Moolgavkar S., Venzon D. Two-event models for carcinogenesis: incidence curves for childhood and adult tumors. Mathematical Biosciences 1979; 47: 55 - 77.
35. Moolgavkar S., Knudson A. Mutation and cancer: a model for human carcinogenesis. Journal of the National Cancer Institute 1981; 66: 1037-52.
36. Moolgavkar S., Luebeck G. Two-event model for carcinogenesis: biological, mathematical, and statistical considerations. Risk Analysis 1990; 10: 323-41.
37. Moolgavkar S., Cross F., Luebeck E., Dagle G. A two-mutation model for radon-induced lung tumors in rats. Radiation Research 1990; 121: 28 - 37.
38. Moolgavkar S., Luebeck G., Krewski D., Zielinski J. Radon, Cigarette Smoke, and Lung Cancer: A re-analysis of the Colorado Plateau uranium miners’ data. Epidemiology 1993; 4: 204-17.
39. Moolgavkar S. et al. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments I: Single agent regimen. Carcinogenesis 1990; 11: 1271-8.
40. Luebeck E., Moolgavkar S., Buchmann A., Schwarz M. Effects of polychlorinated biphenyls in rat liver: Quantitative analysis of enzyme-altered foci. Toxicol Appl Pharmacol 1991; 111: 469-84.
41. US Environmental Protection Agency. Health Assessment Document for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds. Office of Research and Development. EPA/600/BP-92/001b. External Review Draft. June, 1994.
42. Crump KS Limitations of biological models of carcinogenesis for low-dose extrapolation. Risk Analysis 1994; 14(6): 883-6.
43. Crump KS Use of mechanistic models to estimate low dose cancer risks. Risk Analysis 1994; 14 (6): 1033-8.
44. National Research Council. Issues in Risk Assessment. Committee on Risk Assessment Methodology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Academy Press, Washington, D.C., 1993.
45. Anderson ME, Mills JJ, Jirtle RJ, Greenlee WF Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 1995; 102: 233-7.
46. Crump KS A new method for determining allowable daily intakes. Fund Appl Toxicol 1984; 4: 854 - 71.
47. Allen B., Kimmel C., Kavlock R., Faustman E. Dose-response assessment for development toxicity. II. Comparison of generic benchmark dose estimates with NOAELs. Fund Appl Toxicol 1994; 23: 487-95.
48. Crump KS Calculation of benchmark doses from continuous data. Risk Anal 1995; 15: 79 - 89.
49. Usepa. The use of the benchmark dose approach in health risk assessment. EPA/630/R-94/007. February, 1995.
50. Crump KS, Clewell HJ, Andersen, ME Cancer and non-cancer risk assessment should be harmonized. Belle Newsletter 1966; (to appear).